Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative drugs function by mimicking the physiological actions of GLP-1, a hormone produced by https://izaakfbbb325537.luwebs.com/profile